Analog Devices
Change company
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
IE
US
US
US
US
IN
US
US
US
US
US
US
US
US
US
US
US
US
US
AU
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
JP
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
BM
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
CA
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
CA
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
Track Analog Devices in real time with a live news feed covering Analog Devices stock news, official press releases, company announcements, and an archive of historical Analog Devices news. ...more
Loading news...
Loading more...
4:00 PM | Thursday | Aug 27, 2026
Sign in to download news snippet
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta CAR T cell and in vivo CAR T therapies for autoimmune diseases, hematologic malignancies and solid tumors, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Company's Investigational New Drug (IND) application for ADI-212 for the treatment of patients with metastatic castration-resistant prostate cancer (m.
No data available for this time period.
Change the time range to see results.
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta CAR T cell and in vivo CAR T therapies for autoimmune diseases, hematologic malignancies and solid tumors, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Company's Investigational New Drug (IND) application for ADI-212 for the treatment of patients with metastatic castration-resistant prostate cancer (m.
MELVILLE, N.Y.--(BUSINESS WIRE)---- $ADIG--ADI Global Distribution Inc. (NYSE: ADIG) ("ADI"), a leading global specialty distributor of low-voltage products, today announced that Rob Aarnes, President and Chief Executive Officer, will present at the Jefferies 2026 Industrials Conference in New York City on Thursday, September 10, 2026, at 2:50 p.m.
Eastern Time. A live webcast of the presentation will be available through the Events & Presentations section of ADI's Investor Relations website at inves.
MELVILLE, N.Y.--(BUSINESS WIRE)---- $ADIG--ADI Global Distribution Inc. (NYSE: ADIG) ("ADI"), a leading global specialty distributor of low-voltage products, today announced that Rob Aarnes, President and Chief Executive Officer, will present at the Jefferies 2026 Industrials Conference in New York City on Thursday, September 10, 2026, at 2:50 p.m.
Eastern Time. A live webcast of the presentation will be available through the Events & Presentations section of ADI's Investor Relations website at inves.
Revenue of $4.02 billion, with year-over-year growth led by Data Center and Industrial Operating cash flow of $5.5 billion and free cash flow of $4.9 billion on a trailing twelve-month basis or 40% and 36% of revenue, respectively Returned $1.7 billion to shareholders via dividends and share repurchases in the third quarter WILMINGTON, Mass.
, Aug. 19, 2026 /PRNewswire/ -- Analog Devices, Inc. (Nasdaq: ADI), a global semiconductor leader, today announced financial results for its fiscal third quarter 2026, which ended August 1, 2026.
NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, Aug. 4, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor.
Read full article
MELVILLE, N.Y.--(BUSINESS WIRE)---- $ADIG #ADIGonNYSE--ADI Global Distribution Inc. (NYSE: ADIG) (“ADI”), a leading global specialty distributor of low-voltage products, today announced the completion of its spin-off from Resideo Technologies, Inc. (“Resideo”), establishing ADI as an independent publicly traded company.
ADI's common stock will begin “regular way” trading today on the New York Stock Exchange under the ticker symbol “ADIG”. “Today marks a pivotal milestone for ADI as we are officially an independent s.
WILMINGTON, Mass., July 23, 2026 /PRNewswire/ -- Analog Devices, Inc. (Nasdaq: ADI) today announced it will release financial results for the third quarter fiscal year 2026 at 7:00 a.m.
Read full article
WILMINGTON, Mass., July 7, 2026 /PRNewswire/ -- Analog Devices, Inc. (NASDAQ: ADI) today announced the completion of its acquisition of Empower Semiconductor.
Read full articleNEW YORK--(BUSINESS WIRE)--ADI Predictstreet, the Official Prediction Market Partner of the FIFA World Cup 2026™, today announced a strategic branding and product partnership with Kalshi, the world's leading prediction market exchange. This collaboration will expand prediction markets globally, providing billions of fans with new ways to engage with the world's biggest sporting event. Heading into the knockout stage, Kalshi will be co-branded alongside ADI Predictstreet in stadium, TV, and onli.
Read full article
TVM Capital Healthcare secures USD 8M ADI commitment for SEA Fund: resilient healthcare sector and firm's proven track record overcome global uncertainty
Read full article
No data available for this time period.
Change the time range to see results.